Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 41.43
-0.57 (-1.36%)
At close: Apr 30, 2025, 2:57 PM CST
Shanghai OPM Biosciences Revenue
In the year 2024, Shanghai OPM Biosciences had annual revenue of 297.24M CNY with 22.26% growth. Shanghai OPM Biosciences had revenue of 81.39M in the quarter ending December 31, 2024, with 13.93% growth.
Revenue
297.24M
Revenue Growth
+22.26%
P/S Ratio
15.45
Revenue / Employee
918.34K
Employees
328
Market Cap
4.65B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |